IMPAIRED IMMUNE-RESPONSE TO NATURAL INFECTION AS A CORRELATE OF VACCINE FAILURE IN A FIELD TRIAL OF KILLED ORAL CHOLERA VACCINES

被引:7
作者
CLEMENS, J
RAO, M
SACK, D
AHMED, F
KHAN, MR
CHAKRABORTY, J
KAY, B
HUDA, S
YUNUS, M
VANLOON, F
SVENNERHOLM, AM
HOLMGREN, J
机构
[1] INT CTR DIARRHOEAL DIS RES,DHAKA 1000,BANGLADESH
[2] CTR DIS CONTROL & PREVENT,ATLANTA,GA 30341
[3] GOTHENBURG UNIV,GOTHENBURG,SWEDEN
[4] JOHNS HOPKINS UNIV,SCH PUBL HLTH,BALTIMORE,MD
关键词
CHOLERA; CHOLERA VACCINE; SEROEPIDEMIOLOGIC METHODS;
D O I
10.1093/oxfordjournals.aje.a117707
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In a field trial carried out in 1985 in Matlab, Bangladesh, the authors evaluated whether subjects who developed Vibrio cholerae 01 infections during the first year after earlier receipt of B subunit-killed whole cell (BS-WC) or killed whole cell-only (WC) oral cholera vaccines exhibited deficient serum vibriocidal immune responses to these infections. After severe V. cholerae 01 infections (n = 70) in subjects > 5 years of age, the age group in which both vaccines were efficacious, a 6.5 geometric mean-fold rise of serum vibriocidal antibodies was observed among vaccinees, compared with an 18.6 geometric mean-fold rise in placebo-recipients (p < 0.01). Depressions of serum vibriocidal responses among vaccinees were even more marked after asymptomatic infections (n = 30): a 1.1 geometric mean-fold rise in vaccinees versus a 5.9 geometric mean-fold rise in placebo-recipients (p < 0.01). The authors conclude that subjects who failed to be protected by BS-WC and WC, despite being in the age group for which these vaccines were protective, exhibited poor immune responses even to the vigorous stimulus of natural infection. These findings raise the possibility that immune hyporesponsiveness may limit the potential efficacy attainable by cholera vaccines in populations with endemic cholera.
引用
收藏
页码:759 / 764
页数:6
相关论文
共 18 条
[1]  
ARMITAGE P, 1987, STATISTICAL METHODS, P372
[2]  
BENENSON AS, 1968, B WORLD HEALTH ORGAN, V38, P277
[3]   FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESH - RESULTS FROM 3-YEAR FOLLOW-UP [J].
CLEMENS, JD ;
SACK, DA ;
HARRIS, JR ;
VANLOON, F ;
CHAKRABORTY, J ;
AHMED, F ;
RAO, MR ;
KHAN, MR ;
YUNUS, M ;
HUDA, N ;
STANTON, BF ;
KAY, BA ;
WALTER, S ;
EECKELS, R ;
SVENNERHOLM, AM ;
HOLMGREN, J .
LANCET, 1990, 335 (8684) :270-273
[4]   ABO BLOOD-GROUPS AND CHOLERA - NEW OBSERVATIONS ON SPECIFICITY OF RISK AND MODIFICATION OF VACCINE EFFICACY [J].
CLEMENS, JD ;
SACK, DA ;
HARRIS, JR ;
CHAKRABORTY, J ;
KHAN, MR ;
HUDA, S ;
AHMED, F ;
GOMES, J ;
RAO, MR ;
SVENNERHOLM, AM ;
HOLMGREN, J .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (04) :770-773
[5]   FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESH - SERUM VIBRIOCIDAL AND ANTITOXIC ANTIBODIES AS MARKERS OF THE RISK OF CHOLERA [J].
CLEMENS, JD ;
VANLOON, F ;
SACK, DA ;
CHAKRABORTY, J ;
RAO, MR ;
AHMED, F ;
HARRIS, JR ;
KHAN, MR ;
YUNUS, M ;
HUDA, S ;
KAY, BA ;
SVENNERHOLM, AM ;
HOLMGREN, J .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (06) :1235-1242
[6]   EVIDENCE THAT INACTIVATED ORAL CHOLERA VACCINES BOTH PREVENT AND MITIGATE VIBRIO-CHOLERAE O1 INFECTIONS IN A CHOLERA-ENDEMIC AREA [J].
CLEMENS, JD ;
SACK, DA ;
RAO, MR ;
CHAKRABORTY, J ;
KHAN, MR ;
KAY, B ;
AHMED, F ;
BANIK, AK ;
VANLOON, FPL ;
YUNUS, M ;
HARRIS, JR .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (05) :1029-1034
[7]   BIOTYPE AS DETERMINANT OF NATURAL IMMUNIZING EFFECT OF CHOLERA [J].
CLEMENS, JD ;
VANLOON, F ;
SACK, DA ;
RAO, MR ;
AHMED, F ;
CHAKRABORTY, J ;
KAY, BA ;
KHAN, MR ;
YUNUS, M ;
HARRIS, JR ;
SVENNERHOLM, AM ;
HOLMGREN, J .
LANCET, 1991, 337 (8746) :883-884
[9]  
ELSON CO, 1985, J IMMUNOL, V135, P930
[10]   SEROEPIDEMIOLOGICAL STUDIES OF EL-TOR CHOLERA IN BANGLADESH - ASSOCIATION OF SERUM ANTIBODY-LEVELS WITH PROTECTION [J].
GLASS, RI ;
SVENNERHOLM, AM ;
KHAN, MR ;
HUDA, S ;
HUQ, MI ;
HOLMGREN, J .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (02) :236-242